Metabolic Regulation Peptides Bioactive Toxin-Derived Peptides Tumor-Associated Antigen Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Neurodegenerative Disease Research Peptides Melanogenesis Modulation Anti-Aging & Skin Remodeling Gastrin, GRP & Bombesin Peptides Somatostatin Analogs DPPIV/CD26 Peptides Kinase Activity Modulators Caspase Substrates & Inhibitors Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Calcitonin & CGRP Family Peptides Incretin & Metabolic Peptides Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Peptide Coupling Reagents & Additives Specialty Peptide Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Receptor-Targeting Peptides Somatostatin Analogs Octreotide Acetate | SSTR2 Somatostatin Analog

DESCRIPTION

Octreotide acetate is a cyclic octapeptide somatostatin analog designed around the receptor-active region of native somatostatin. Its compact structure contains two D-amino acids, an intramolecular disulfide bond, and a C-terminal threoninol residue that distinguish it from native somatostatin-14.

Octreotide preferentially activates somatostatin receptor subtype 2 (SSTR2) and is widely used as a reference ligand in somatostatin receptor pharmacology, GPCR signaling, receptor internalization and peptide structure–activity studies.

Product Information

PropertySpecification
Product NameOctreotide Acetate
CAS No.79517-01-4
SequenceD-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol
Peptide Length8 amino-acid residues
Molecular WeightApproximately 1019.3 Da for the octreotide free peptide
Salt FormAcetate
Disulfide BondCys2–Cys7
C-TerminusThreoninol (Thr-ol)
Primary TargetSSTR2
Research AreasSomatostatin receptor pharmacology, GPCR signaling, peptide SAR, receptor internalization

Octreotide Sequence and Cyclic Structure

The peptide sequence is:

D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol

An intramolecular disulfide bond between Cys2 and Cys7 constrains the peptide into the cyclic conformation associated with somatostatin receptor recognition.

Octreotide also contains D-Phe1 and D-Trp4 together with a reduced C-terminal threoninol residue. These structural features contribute to the distinct conformational and stability properties of the molecule compared with native somatostatin peptides.

We consider the disulfide state, D-amino-acid configuration and C-terminal Thr-ol to be part of the intended molecular identity. HPLC purity alone does not establish that all three structural features are correct.

Somatostatin Receptor Pharmacology

Octreotide shows its strongest pharmacological activity at SSTR2, with additional activity at SSTR5 and lower activity at SSTR3 in commonly used human receptor systems. Activity at SSTR1 and SSTR4 is substantially weaker.

ReceptorOctreotide Research Profile
SSTR2Primary high-affinity receptor
SSTR5Secondary receptor activity
SSTR3Lower activity
SSTR1 / SSTR4Weak activity in commonly used receptor assays

Cryo-EM studies have directly resolved octreotide bound to human SSTR2 and, more recently, SSTR5. These structures provide a molecular framework for studying receptor subtype selectivity, ligand recognition and analog design.

Researchers working with related receptor ligands can explore our Somatostatin Analogs collection.

Acetate Salt and Molecular Weight

Octreotide acetate should be distinguished from the octreotide peptide backbone when molecular weight and composition are reported.

The octreotide free peptide has a molecular weight of approximately 1019.3 Da. In the acetate form, acetate is present as a counterion and the total mass depends on acetate stoichiometry and the way the material is specified.

We recommend checking whether a reported molecular weight refers to octreotide itself or the complete acetate-containing material when comparing specifications between suppliers or preparing quantitative experiments.

Synthetic and Quality Control Considerations

Octreotide requires controlled assembly of D- and L-amino acids, correct Cys2–Cys7 oxidation and preservation of the C-terminal threoninol structure. Incorrect oxidation or stereochemistry can produce material with the expected nominal sequence but different biological behavior.

For receptor-binding and cell-based studies, we recommend confirming molecular identity together with chromatographic purity. Our Peptide Quality Control capabilities include analytical HPLC and mass spectrometry with batch-specific documentation according to the selected specification.

Octreotide analogs, sequence variants and cyclic peptide projects can also be evaluated through our Chemical Peptide Synthesis capabilities.

Frequently Asked Questions

How many amino acids are in Octreotide?

Octreotide contains eight amino-acid residues and is therefore classified as a cyclic octapeptide.

What is the disulfide bond in Octreotide?

The peptide contains one intramolecular disulfide bond between Cys2 and Cys7.

Which somatostatin receptor does Octreotide preferentially target?

Octreotide preferentially activates SSTR2. It also has activity at SSTR5 and SSTR3, with receptor potency depending on the assay system and experimental conditions.

Why can different molecular weights be reported for Octreotide Acetate?

The octreotide peptide itself has a molecular weight of approximately 1019.3 Da. Acetate is a counterion, so reported values can differ depending on whether the specification refers to the free peptide or an acetate-containing molecular composition.

Research Use Only.

Octreotide Acetate | SSTR2 Somatostatin Analog

Catalog No: AS2513
Cas No: 79517-01-4

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}
Submit